# Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial

> **NCT07374562** · NA · RECRUITING · sponsor: **Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec** · enrollment: 40 (estimated)

## Conditions studied

- Long COVID

## Interventions

- **PROCEDURE:** Stellate Ganglion Block (Bupivacaine)
- **PROCEDURE:** placebo saline injection

## Key facts

- **NCT ID:** NCT07374562
- **Lead sponsor:** Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-05
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07374562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07374562, "Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07374562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*